Alphatec Holdings Announces Proposed Public Offering of Common Stock
12 April 2010 - 1:03PM
Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of
Alphatec Spine, Inc., a medical device company that designs,
develops, manufactures and markets products for the surgical
treatment of spine disorders, with a focus on treating conditions
related to the aging spine, announced that it is offering to sell
8,000,000 primary shares of its common stock and a selling
shareholder, HealthpointCapital Partners, L.P., is offering
8,000,000 shares of Alphatec common stock in an underwritten public
offering. Jefferies & Company, Inc. is acting as lead
book-running manager for the offering, with Canaccord Adams Inc.
acting as joint book-running manager and Cowen and Company, LLC and
Lazard Capital Markets LLC acting as co-managers.
Alphatec Holdings and the selling shareholder have each granted
the underwriters an option to purchase up to an additional
1,200,000 shares (2,400,000 shares in the aggregate) of common
stock to cover overallotments of shares, if any. The offering is
subject to market conditions, and there can be no assurance as to
whether or when the offering may be completed, or as to the actual
size or terms of the offering.
The securities described above are being offered pursuant to a
shelf registration statement previously filed with and declared
effective by the Securities and Exchange Commission (the "SEC") on
April 9, 2010. A preliminary prospectus supplement related to
the offering has been filed with the SEC and is available on the
SEC's web site at http://www.sec.gov. Copies of the
preliminary prospectus supplement relating to these securities may
be obtained from Jefferies & Company, Inc., Attention:
Syndicate Prospectus Department, 520 Madison Avenue, New York, NY,
10022 and at (888) 449-2342. This press release shall not
constitute an offer to sell or the solicitation of an offer to buy
these securities, nor shall there be any sale of these securities
in any state or other jurisdiction in which such offer,
solicitation or sale would be unlawful prior to the registration or
qualification under the securities laws of any such state or other
jurisdiction.
About Alphatec Spine
Alphatec Spine, Inc. is a wholly owned subsidiary of Alphatec
Holdings, Inc. (Nasdaq:ATEC). Alphatec Spine is a medical device
company that designs, develops, manufactures and markets products
for the surgical treatment of spine disorders, primarily focused on
the aging spine. The Company's mission is to combine
world-class customer service with innovative, surgeon-driven design
that will help improve the aging patient's quality of
life. The Company is poised to achieve its goal through new
solutions for patients with osteoporosis, stenosis and other aging
spine deformities, improved minimally invasive products and
techniques and integrated biologics solutions. In addition to
its U.S. operations, the Company also markets its products in over
50 international markets through its subsidiary, Scient'x S.A., via
a direct salesforce in France, Italy and the United Kingdom and via
independent distributors in the rest of Europe, the Middle East and
Africa, South America and Latin America. In Asia and
Australia, the Company markets its products through its subsidiary,
Alphatec Pacific, Inc, and through Scient'x's distributors in
China, Korea and Australia.
The Alphatec Holdings, Inc. logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=3520
CONTACT: Alphatec Spine, Inc.
Peter C. Wulff, Chief Financial Officer
(760) 494-6746
investorrelations@alphatecspine.com
Westwicke Partners
Lynn C. Pieper
(415) 202-5678
lynn.pieper@westwicke.com
Alphatec (NASDAQ:ATEC)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Alphatec (NASDAQ:ATEC)
Historical Stock Chart
Von Jul 2023 bis Jul 2024